901309-17-9Relevant academic research and scientific papers
Studies towards the development of a PET radiotracer for imaging of the P2Y1 receptors in the brain: synthesis, 18F-labeling and preliminary biological evaluation
Moldovan, Rare?-Petru,Wenzel, Barbara,Teodoro, Rodrigo,Neumann, Wilma,Dukic-Stefanovic, Sladjana,Kraus, Werner,Rong, Peijing,Deuther-Conrad, Winnie,Hey-Hawkins, Evamarie,Krügel, Ute,Brust, Peter
, p. 142 - 159 (2019/01/23)
Purine nucleotides such as ATP and ADP are important extracellular signaling molecules in almost all tissues activating various subtypes of purinoreceptors. In the brain, the P2Y1 receptor (P2Y1R) subtype mediates trophic functions l
2-Aminothiazole based P2Y1 antagonists as novel antiplatelet agents
Pi, Zulan,Sutton, James,Lloyd, John,Hua, Ji,Price, Laura,Wu, Qimin,Chang, Ming,Zheng, Joanna,Rehfuss, Robert,Huang, Christine S.,Wexler, Ruth R.,Lam, Patrick Y.S.
, p. 4206 - 4209 (2013/07/25)
ADP receptors, P2Y1 and P2Y12 have been recognized as potential targets for antithrombotic drugs. A series of P2Y1 antagonists that contain 2-aminothiazoles as urea surrogates were discovered. Extensive SAR of the thiazole
Heteroaryl compounds as P2Y1 receptor inhibitors
-
Page/Page column 62, (2008/06/13)
The present invention provides novel heteroaryl compounds and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
